F.D.A. Approves New Obesity Drug That Will Compete With Wegovy

Zepbound, which is already sold by Eli Lilly as the diabetes treatment Mounjaro, was shown to reduce patients’ weight by as much as one-fifth in drug trials.

Gina Kolata | NYTimes Health | Disclosure